Gland Pharma Gets EU GMP Nod

  Published 10 months ago

Gland Pharma’s Pashamylaram facility receives EU GMP certification from Denmark for aseptic powder injection, infusion, and inhalation.

  • Certification covers marketing authorizations for non-EEA manufacturers, boosting export prospects to European markets.
  • Facility approval enhances compliance credibility and supports growth in regulated markets.
  • Products include aseptically prepared powder for injection, infusion, and inhalation therapies.

You might like these

CMS Info Systems Stock Jumps on Positive Outlook

Goldman Sachs Bets on Rupee Rally: 3% Gain Expected

Sensex Reshuffle: BAJE & TREN In, INBK & NEST Out

HDB Financial Services IPO Surpasses 16x Subscription

ideaForge Q1 Loss Widens, Order Boost

SEBI Plans Major Revamp of IPO Rules

US-India Trade Deal Nears Finalization

News that matters the most ⚡